181 related articles for article (PubMed ID: 25096551)
1. Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Anderson SA; Barry JA; Hardiman PJ
Int J Cardiol; 2014 Sep; 176(2):486-7. PubMed ID: 25096551
[No Abstract] [Full Text] [Related]
2. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis.
de Groot PC; Dekkers OM; Romijn JA; Dieben SW; Helmerhorst FM
Hum Reprod Update; 2011; 17(4):495-500. PubMed ID: 21335359
[TBL] [Abstract][Full Text] [Related]
3. Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke.
Zhu T; Cui J; Goodarzi MO
Diabetes; 2021 Feb; 70(2):627-637. PubMed ID: 33158931
[TBL] [Abstract][Full Text] [Related]
4. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis.
Zhao L; Zhu Z; Lou H; Zhu G; Huang W; Zhang S; Liu F
Oncotarget; 2016 Jun; 7(23):33715-21. PubMed ID: 27220885
[TBL] [Abstract][Full Text] [Related]
6. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.
Lizneva D; Kirubakaran R; Mykhalchenko K; Suturina L; Chernukha G; Diamond MP; Azziz R
Fertil Steril; 2016 Nov; 106(6):1510-1520.e2. PubMed ID: 27530062
[TBL] [Abstract][Full Text] [Related]
7. To determine whether first-degree male relatives of women with polycystic ovary syndrome are at higher risk of developing cardiovascular disease and type II diabetes mellitus.
Hunter A; Vimplis S; Sharma A; Eid N; Atiomo W
J Obstet Gynaecol; 2007 Aug; 27(6):591-6. PubMed ID: 17896258
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
Sirmans SM; Parish RC; Blake S; Wang X
J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
10. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis.
Toulis KA; Goulis DG; Kolibianakis EM; Venetis CA; Tarlatzis BC; Papadimas I
Fertil Steril; 2009 Aug; 92(2):667-77. PubMed ID: 18710713
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
12. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
Talbott EO; Zborowskii JV; Boudraux MY
Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
[TBL] [Abstract][Full Text] [Related]
13. Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis.
Deswal R; Yadav A; Dang AS
Syst Biol Reprod Med; 2018 Feb; 64(1):12-24. PubMed ID: 29227165
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.
Christian RC; Dumesic DA; Behrenbeck T; Oberg AL; Sheedy PF; Fitzpatrick LA
J Clin Endocrinol Metab; 2003 Jun; 88(6):2562-8. PubMed ID: 12788855
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
[TBL] [Abstract][Full Text] [Related]
16. Criteria, prevalence, and phenotypes of polycystic ovary syndrome.
Lizneva D; Suturina L; Walker W; Brakta S; Gavrilova-Jordan L; Azziz R
Fertil Steril; 2016 Jul; 106(1):6-15. PubMed ID: 27233760
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.
Bacopoulou F; Kolias E; Efthymiou V; Antonopoulos CN; Charmandari E
Eur J Clin Invest; 2017 Oct; 47(10):746-755. PubMed ID: 28795765
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitors for subfertile women with polycystic ovary syndrome: summary of a Cochrane review.
Franik S; Kremer JA; Nelen WL; Farquhar C; Marjoribanks J
Fertil Steril; 2015 Feb; 103(2):353-5. PubMed ID: 25455536
[TBL] [Abstract][Full Text] [Related]
19. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
